课题基金 / 基金详情

preclinical Testing of Novel Therapies in FA

preclinical Testing of Novel Therapies in FA
FA 中新疗法的临床前测试
批准号：
8255537
负责人：
Markus Grompe
金额：
$30.17万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
项目状态：
已结题
起止时间：
2011-04-01 至 2015-03-31
来源：
https://reporter.nih.gov/project-details/8255537
关键词：
Acute Myelocytic LeukemiaAndrogen ReceptorAndrogensAnemiaBiological AssayBone MarrowCafe-au-Lait SpotCause of DeathCellsClinicalCongenital AbnormalityDiseaseDrug usageFailureFanconi&aposs AnemiaFunctional disorderGene ExpressionGene Transduction AgentGenesHematopoiesisHematopoieticHematopoietic stem cellsHemorrhageHumanIn VitroKnockout MiceLongevityMalignant NeoplasmsMarrowMeasuresMediatingMethodsMicrophthalmosModelingMolecularMusOrganOxidantsOxymetholonePancytopeniaPatientsPharmaceutical PreparationsPluripotent Stem CellsPreclinical TestingRadialRare DiseasesResveratrolScreening procedureSignal PathwaySolidSolid NeoplasmSquamous cell carcinomaStem cellsSuperoxide DismutaseTestingTherapeuticThioctic AcidThumb structureadeno-associated viral vectoranalogcancer preventionclinically relevantefficacy testinggene discoverygene repairgene therapyimprovedin vivomutantnovelpreventprogenitorsmall moleculestemtempoltumor

项目摘要

项目成果

Markus Grompe的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
FA is a rare disease and about 500 patients with FA are alive in the U.S.A. The 3 main clinical features of FA are birth defects (missing thumb/radius; microphthalmia; cafe-au-lait spots etc.), progressive marrow failure and cancer suscepfibility [1]. In FA. the life span Is severely shortened [2]. The main cause of death is bone marrow failure with the associated complications of anemia, bleeding and infecfion. Another cause of death is cancer, particulariy acute myelogenous leukemia, but also solid tumors, particulariy squamous cell carcinomas [3].
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo selection of gene modified hepatocytes
In vivo selection of gene modified hepatocytes
In vivo selection of gene modified hepatocytes
Gene Therapy for Diabetes
海外基金